FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3032130109> ?p ?o ?g. }

• W3032130109 endingPage "972" @default.
• W3032130109 startingPage "968" @default.
• W3032130109 abstract "Background Neovascular glaucoma (NVG) is a serious ocular disease which may cause blindness.The primary pathogenesis of NVG is ischemic retinopathy derived by central retinal vein occlusion (CRVO) and diabetic retinopathy (DR).Clinical characteristics of NVG are variable based on the difference of primary diseases,such as CRVO and DR.However,there is a few studies regarding the diffcrcnces of NVG initiated by CRVO and DR.Objective This study was to compare the clinical characteristics in NVG patients secondary to CRVO and DR.Methods A series case observational study was carried out in Hiserve Hospital of Qingdao University from January 2009 to June 2012.Twenty-nine eyes of 27 patients with NVG caused by CRVO (10 eyes of 10 patients) and DR (19 eyes of 17 patients) were included.The history of underlying diseases,course of NVG,intraocular pressure(IOP),fundus findings and complications after treatment were analyzed and compared between the CRVO-derived NVG and DR-derived NVG.All patients underwent panretinal photocoagulation,improving microcirculation therapy,anti-glaucoma (drug or surgery) and causative disease treatment,and some of them received vitrectomy or/and cataract surgery.Two eyes from each group received intravitreal injection of ranibizumab.The follow-up time in both groups was (14.00±10.13) months and (17.89±12.52) months,respectively.Results The median time of underlying disease was 3.3 months (2 weeks to 6 months) in the CRVO patients and 11.1 months (4 to 36 mouths) in the DR patients,with a significant difference between them (Z =-2.40,P＜0.05).CRVO-derived NVG progress was much faster than that of DR-derived NVG.The number of the eyes with visual acuity improvement after treatment was 2 in the CRVO-derived NVG and 15 in the DR-derived NVG;while the number of the eyes with unchanged or worse visual acuity was 8 and 4 in the CRVO-derived NVG eyes and the DR-derived NVG eyes (x2 =9.38,P＜0.01).The difference of IOP in pre-and post-treatment was (37.00±9.91)mmHg in the CRVOderived NVG eyes and (8.92±12.05)mmHg in the DR-derived NVG eyes,showing a significant difference between them (t =6.30,P＜0.01).In the CRVO-derived NVG eyes,optic disc edema,retinal hemorrhage,and vein dilatation were seen in 6 eyes,and mild optic disc edema and retinal hemorrhage were observed in 4 eyes.After treatment,fundus could not be seen in 4 eyes,in other 2 eyes optic disc and retinal laser spots were unclearly observed.In addition,pale optic disc and retinal vessel occlusion appeared in 2 eyes,and silver wire-like arteries exhibited in 2 eyes.In pre-treated DR-derived NVG eyes,fundus could not be seen in 8 eyes and Ⅲ-Ⅳv stages of DR findings appeared in 11 eyes.After treatment,retinopathy was stabilized in 16 eyes of 15 cases.Advanced retinopathy(V-Ⅵ stages of DR findings) was revealed in 3 eyes of 3 cases.The incidence of the complication after treatment was 100.0％ in the CRVO-derived NVG eyes and 21.1％ in the DR-derived NVG eyes (x2=5.18,P＜0.05).Conclusions The clinical characteristics of NVG secondary to CRVO and DR are variable,an appropriate treatment option should be selected according to different features of NVG.Key words: Glaucoma/neovascular, refractory; Central retinal vein occlusion; Diabetic mellitus/complication, retinopathy; Clinical characteristic; Prognosis" @default.
• W3032130109 created "2020-06-05" @default.
• W3032130109 creator A5003260108 @default.
• W3032130109 creator A5028681334 @default.
• W3032130109 creator A5028867092 @default.
• W3032130109 creator A5060381379 @default.
• W3032130109 creator A5078221510 @default.
• W3032130109 date "2013-10-10" @default.
• W3032130109 modified "2023-09-29" @default.
• W3032130109 title "Clinical characteristics of neovascular glaucoma secondary to central retinal vein occlusion and diabetic retinopathy" @default.
• W3032130109 doi "https://doi.org/10.3760/cma.j.issn.2095-0160.2013.10.014" @default.
• W3032130109 hasPublicationYear "2013" @default.
• W3032130109 type Work @default.
• W3032130109 sameAs 3032130109 @default.
• W3032130109 citedByCount "0" @default.
• W3032130109 crossrefType "journal-article" @default.
• W3032130109 hasAuthorship W3032130109A5003260108 @default.
• W3032130109 hasAuthorship W3032130109A5028681334 @default.
• W3032130109 hasAuthorship W3032130109A5028867092 @default.
• W3032130109 hasAuthorship W3032130109A5060381379 @default.
• W3032130109 hasAuthorship W3032130109A5078221510 @default.
• W3032130109 hasConcept C118487528 @default.
• W3032130109 hasConcept C134018914 @default.
• W3032130109 hasConcept C141071460 @default.
• W3032130109 hasConcept C2776391266 @default.
• W3032130109 hasConcept C2776694085 @default.
• W3032130109 hasConcept C2777802072 @default.
• W3032130109 hasConcept C2778527774 @default.
• W3032130109 hasConcept C2778844676 @default.
• W3032130109 hasConcept C2779829184 @default.
• W3032130109 hasConcept C2780347916 @default.
• W3032130109 hasConcept C2780827179 @default.
• W3032130109 hasConcept C2781100027 @default.
• W3032130109 hasConcept C3020578304 @default.
• W3032130109 hasConcept C555293320 @default.
• W3032130109 hasConcept C71924100 @default.
• W3032130109 hasConceptScore W3032130109C118487528 @default.
• W3032130109 hasConceptScore W3032130109C134018914 @default.
• W3032130109 hasConceptScore W3032130109C141071460 @default.
• W3032130109 hasConceptScore W3032130109C2776391266 @default.
• W3032130109 hasConceptScore W3032130109C2776694085 @default.
• W3032130109 hasConceptScore W3032130109C2777802072 @default.
• W3032130109 hasConceptScore W3032130109C2778527774 @default.
• W3032130109 hasConceptScore W3032130109C2778844676 @default.
• W3032130109 hasConceptScore W3032130109C2779829184 @default.
• W3032130109 hasConceptScore W3032130109C2780347916 @default.
• W3032130109 hasConceptScore W3032130109C2780827179 @default.
• W3032130109 hasConceptScore W3032130109C2781100027 @default.
• W3032130109 hasConceptScore W3032130109C3020578304 @default.
• W3032130109 hasConceptScore W3032130109C555293320 @default.
• W3032130109 hasConceptScore W3032130109C71924100 @default.
• W3032130109 hasIssue "10" @default.
• W3032130109 hasLocation W30321301091 @default.
• W3032130109 hasOpenAccess W3032130109 @default.
• W3032130109 hasPrimaryLocation W30321301091 @default.
• W3032130109 hasRelatedWork W110243738 @default.
• W3032130109 hasRelatedWork W1572712634 @default.
• W3032130109 hasRelatedWork W1980869219 @default.
• W3032130109 hasRelatedWork W2034184649 @default.
• W3032130109 hasRelatedWork W2093117582 @default.
• W3032130109 hasRelatedWork W2362599925 @default.
• W3032130109 hasRelatedWork W2912004292 @default.
• W3032130109 hasRelatedWork W2977429015 @default.
• W3032130109 hasRelatedWork W2979925250 @default.
• W3032130109 hasRelatedWork W3007932248 @default.
• W3032130109 hasRelatedWork W3030693705 @default.
• W3032130109 hasRelatedWork W3031427833 @default.
• W3032130109 hasRelatedWork W3031769353 @default.
• W3032130109 hasRelatedWork W3032344950 @default.
• W3032130109 hasRelatedWork W3088082778 @default.
• W3032130109 hasRelatedWork W3203057625 @default.
• W3032130109 hasRelatedWork W3203722721 @default.
• W3032130109 hasRelatedWork W3209797814 @default.
• W3032130109 hasRelatedWork W78826777 @default.
• W3032130109 hasRelatedWork W3029826108 @default.
• W3032130109 hasVolume "31" @default.
• W3032130109 isParatext "false" @default.
• W3032130109 isRetracted "false" @default.
• W3032130109 magId "3032130109" @default.
• W3032130109 workType "article" @default.